View |
|
DR-XY49032
|
0.9% Sodium Chloride
|
None
|
9 mg/mL (0.9% w/v)
|
Solution for Injection (IV
Infusion)
|
Electrolyte Replenisher
|
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
|
China
|
Initial
|
02 April 2024
|
02 April 2029
|
View |
|
DR-XY49033
|
0.9% Sodium Chloride
|
None
|
9 mg/mL (0.9% w/v)
|
Solution for Injection (IV
Infusion)
|
Electrolyte Replenisher
|
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
|
China
|
Initial
|
02 April 2024
|
02 April 2029
|
View |
|
DRP-15068
|
Hydroxychloroquine Sulfate
|
None
|
200mg
|
Film-Coated Tablet
|
Antimalarial (Aminoquinolines)
|
Bafna Pharmaceuticals Limited
|
India
|
Initial
|
04 April 2024
|
04 April 2029
|
View |
|
DR-XY49037
|
Meropenem (as trihydrate)
|
Aemero 500
|
500 mg
|
Powder for Injection (I.V.)
|
Antibacterial (Carbapenem)
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
Initial
|
05 April 2024
|
05 April 2029
|
View |
|
DR-XY49036
|
Meropenem (as trihydrate)
|
Aemero 1000
|
1 g
|
Powder for Injection (I.V.)
|
Antibacterial (Carbapenem)
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
Initial
|
05 April 2024
|
05 April 2029
|
View |
|
DRP-15069
|
Levetiracetam
|
Levsezur
|
100 mg/mL
|
Oral Solution
|
Antiepileptic
|
Novagen Healthcare Private Limited
|
India
|
Initial
|
04 April 2024
|
04 April 2029
|
View |
|
DRP-15070
|
Levetiracetam
|
None
|
100mg/mL
|
Oral Solution
|
Antiepileptic
|
Novagen Healthcare Private Limited
|
India
|
Initial
|
04 April 2024
|
04 April 2029
|
View |
|
DR-XY49035
|
Rivaroxaban
|
Verxaban
|
10 mg
|
Film-Coated Tablet
|
Antithrombotic Agent (Direct factor Xa inhibitor)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
04 April 2024
|
04 April 2029
|
View |
|
DR-XY49034
|
Rivaroxaban
|
Verxaban
|
15 mg
|
Film-Coated Tablet
|
Antithrombotic Agent (Direct factor Xa inhibitor)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
04 April 2024
|
04 April 2029
|
View |
|
DRP-15071
|
Tobramycin (as sulfate) + Dexamethasone
|
Tobramet
|
3 mg/1 mg per mL (0.3% /0.1% w/v)
|
Ophthalmic
Suspension
|
Antibacterial and Corticosteroid
|
Indiana Ophthalmics
|
India
|
Initial
|
04 April 2024
|
04 April 2029
|
View |
|
BR-1480
|
Spesolimab
|
Spevigo
|
450 mg/7.5 mL (60 mg/mL)
|
Concentrate for Solution for
Infusion (IV)
|
Interleukin inhibitors
|
Boehringer Ingelheim Pharma GmbH & Co. KG
|
Germany
|
Monitored Release (MR)
|
05 April 2024
|
05 April 2029
|
View |
|
DRP-15022
|
Mupirocin
|
Mupisur
|
20 mg/g (2% w/w)
|
Cream
|
Antibacterial
|
Kwality Pharmaceuticals Limited
|
India
|
Initial [OTC]
|
04 April 2024
|
04 April 2029
|
View |
|
DRP-15067
|
Hydroxychoroquine Sulfate
|
H-Klor
|
200mg
|
Film-Coated Tablet
|
Antimalarial (Aminoquinolines)
|
Bafna Pharmaceuticals Limited
|
India
|
Initial
|
08 April 2024
|
08 April 2029
|
View |
|
DRP-10604-05
|
Levodropropizine
|
Pecof Dry
|
30 mg/5 mL
|
Syrup
|
Cough Suppressant
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
29 May 2023
|
22 October 2026
|
View |
|
DRP-10604-04
|
Levodropropizine
|
Levopres
|
30 mg/5 mL
|
Syrup
|
Cough Suppressant
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
26 April 2023
|
22 October 2026
|
View |
|
DRP-10604-02
|
Levodropropizine
|
Rapifort
|
30 mg/5 mL
|
Syrup
|
Cough Suppressant
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
09 February 2023
|
22 October 2026
|
View |
|
DRP-10604-03
|
Levodropropizine
|
Peritus
|
30 mg/5 mL
|
Syrup
|
Cough Suppressant
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
11 February 2023
|
22 October 2026
|
View |
|
DRP-15072
|
Ofloxacin
|
Ofloxasaph-INF
|
2 mg/mL (200 mg/100 mL)
|
Solution for Intravenous
Infusion
|
Antibacterial (Fluoroquinolone)
|
Althea Pharma Pvt. Ltd.
|
India
|
Initial
|
12 April 2024
|
12 April 2029
|
View |
|
DRP-15074
|
Norepinephrine (as bitartrate)
|
Norepin 16
|
1 mg/mL (16 mg/16 mL)
|
Concentrate Solution. for IV Infusion
|
Adrenergic Agent
|
United Biotech Pvt. Ltd.
|
India
|
Initial
|
12 April 2024
|
12 April 2029
|
View |
|
DRP-15073
|
Methotrexate
|
Trexglo
|
2.5 mg
|
Tablet
|
Antineoplastic
|
Globela Pharma Private Limited
|
India
|
Initial
|
12 April 2024
|
12 April 2029
|